Aspiration Biopsy Versus Dilatation and Curettage for Endometrial Hyperplasia Prior to Hysterectomy

Overview

Journal Diagn Pathol

Publisher Biomed Central

Specialty Pathology

Date 2021 Jan 14

PMID 33441173

Citations 5

Authors

Woo Yeon Hwang

Dong Hoon Suh

Kidong Kim

Jae Hong No

Yong Beom Kim

Affiliations

Soon will be listed here.

Abstract

Background: To compare the diagnostic accuracy of aspiration biopsy and dilatation and curettage (D&C) in patients diagnosed with endometrial hyperplasia prior to hysterectomy.

Methods: We retrospectively reviewed medical records of 250 patients diagnosed with endometrial hyperplasia by endometrial sampling between July 2003 and March 2020. Endometrial sampling was performed by aspiration biopsy (n = 150) or D&C (n = 100), followed by hysterectomy within 6 months. Pathological findings of hysterectomy specimens of the two groups were compared to preoperative findings.

Results: The overall diagnostic concordance between endometrial sampling specimen including D&C and aspiration biopsy, and hysterectomy specimen was 51.0% (51/100) and 41.3% (62/150), respectively. Patients whose preoperative specimen was obtained by D&C were upgraded less significantly than those who underwent aspiration biopsy (21.0% vs 36.7%; P = 0.008). In particular, significantly fewer patients were upgraded after D&C than after aspiration biopsy in hyperplasia without atypia (12.5% vs 29.0%; P = 0.028). In addition, when the final pathological upgrade rate to endometrial carcinoma was evaluated between the two methods of endometrial sampling, significantly fewer cases were noted after D&C than after aspiration biopsy (15.0% vs 27.3%; P = 0.022).

Conclusions: In our study, D&C more accurately reflected the final diagnosis in patients with endometrial hyperplasia than aspiration biopsy based on the histological examination of hysterectomy specimens. When considering the management strategy for women with an endometrial hyperplasia diagnosis obtained by aspiration biopsy, physicians should consider the significant rate of upgraded diseases with this method of endometrial sampling.

Citing Articles

Multiparameter MRI-based radiomics analysis for preoperative prediction of type II endometrial cancer.

Cao Y, Zhang W, Wang X, Lv X, Zhang Y, Guo K Heliyon. 2024; 10(12):e32940.

PMID: 38988546 PMC: 11234004. DOI: 10.1016/j.heliyon.2024.e32940.

When Less Is More - Pipelle Endometrial Sampling for Quantification of Uterine Natural Killer Cells in Patients With Recurrent Implantation Failure or Habitual Abortion.

Lapides L, Varga I, Klein M, Rybanska L, Belusakova V, Babal P Physiol Res. 2023; 71(Suppl 1):S65-S73.

PMID: 36592442 PMC: 9854003.

Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis.

Rao Q, Liao J, Li Y, Zhang X, Xu G, Zhu C Cancer Med. 2022; 12(5):5409-5419.

PMID: 36341543 PMC: 10028062. DOI: 10.1002/cam4.5363.

Manual vacuum aspiration (women's MVA) for endometrial biopsy for patients with suspected endometrial malignancies.

Saito E, Matsumoto Y, Nitta S, Fujino S, Tsuruga T, Mori-Uchino M J Obstet Gynaecol Res. 2022; 48(11):2896-2902.

PMID: 36054542 DOI: 10.1111/jog.15403.

Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding in Daily Clinical Practice: Why the Approach to Patients Should Be Personalized?.

Tanko N, Linkov F, Bapayeva G, Ukybassova T, Kaiyrlykyzy A, Aimagambetova G J Pers Med. 2021; 11(10).

PMID: 34683110 PMC: 8539706. DOI: 10.3390/jpm11100970.

References

Sanam M, Majid M . Comparison the Diagnostic Value of Dilatation and Curettage Versus Endometrial Biopsy by Pipelle--a Clinical Trial. Asian Pac J Cancer Prev. 2015; 16(12):4971-5. DOI: 10.7314/apjcp.2015.16.12.4971. View

Nair R, Bandhe S, Ganorkar O, Saha S, Sial S, Nair A . A comparative evaluation of the three different antioxidant treatments on the bond strength of composite resin to bleached enamel: An study. J Conserv Dent. 2019; 22(1):82-86. PMC: 6385577. DOI: 10.4103/JCD.JCD_193_18. View

Sobczuk K, Sobczuk A . New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Prz Menopauzalny. 2018; 16(3):107-111. PMC: 5834925. DOI: 10.5114/pm.2017.70589. View

Ferry J, Farnsworth A, Webster M, Wren B . The efficacy of the pipelle endometrial biopsy in detecting endometrial carcinoma. Aust N Z J Obstet Gynaecol. 1993; 33(1):76-8. DOI: 10.1111/j.1479-828x.1993.tb02060.x. View

Stovall T, Photopulos G, Poston W, Ling F, Sandles L . Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol. 1991; 77(6):954-6. View

Merisio C, Berretta R, De Ioris A, Pultrone D, Rolla M, Giordano G . Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol. 2005; 122(1):107-11. DOI: 10.1016/j.ejogrb.2005.01.001. View

Demirkiran F, Yavuz E, Erenel H, Bese T, Arvas M, Sanioglu C . Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C). Arch Gynecol Obstet. 2012; 286(5):1277-82. DOI: 10.1007/s00404-012-2438-8. View

Kim M, Seong S, Lee T, Ki K, Lim M, Kim Y . Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019). Jpn J Clin Oncol. 2015; 45(10):980-2. DOI: 10.1093/jjco/hyv106. View

Dijkhuizen F, Mol B, Brolmann H, Heintz A . The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000; 89(8):1765-72. View

10.

Suh-Burgmann E, Hung Y, Armstrong M . Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage. Obstet Gynecol. 2009; 114(3):523-529. DOI: 10.1097/AOG.0b013e3181b190d5. View

11.

Kim M, Seong S, Park D, Hong J, Roh J, Kang S . Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study. J Gynecol Oncol. 2020; 31(4):e51. PMC: 7286758. DOI: 10.3802/jgo.2020.31.e51. View

12.

Zorlu C, Cobanoglu O, Isik A, Kutluay L, Kuscu E . Accuracy of pipelle endometrial sampling in endometrial carcinoma. Gynecol Obstet Invest. 1994; 38(4):272-5. DOI: 10.1159/000292495. View

13.

. The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia. Obstet Gynecol. 2015; 125(5):1272-1278. DOI: 10.1097/01.AOG.0000465189.50026.20. View

14.

Chandra V, Kim J, Benbrook D, Dwivedi A, Rai R . Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2015; 27(1):e8. PMC: 4695458. DOI: 10.3802/jgo.2016.27.e8. View

15.

Guido R, Kanbour-Shakir A, Rulin M, Christopherson W . Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med. 1995; 40(8):553-5. View

16.

Antoni J, Folch E, Costa J, Foradada C, Cayuela E, Combalia N . Comparison of cytospat and pipelle endometrial biopsy instruments. Eur J Obstet Gynecol Reprod Biol. 1997; 72(1):57-61. DOI: 10.1016/s0301-2115(96)02658-9. View

17.

Yi Y, Bryce C, Adambekov S, Edwards R, Goughnour S, Linkov F . Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage. Gynecol Oncol. 2018; 150(1):112-118. DOI: 10.1016/j.ygyno.2018.04.565. View

18.

Kadirogullari P, Atalay C, Ozdemir O, Sari M . Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia. J Clin Diagn Res. 2015; 9(10):QC10-4. PMC: 4625289. DOI: 10.7860/JCDR/2015/12484.6618. View

19.

Abdelazim I, Aboelezz A, Abdulkareem A . Pipelle endometrial sampling versus conventional dilatation & curettage in patients with abnormal uterine bleeding. J Turk Ger Gynecol Assoc. 2014; 14(1):1-5. PMC: 3881726. DOI: 10.5152/jtgga.2013.01. View